Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis

Rosa Andres Ejarque(Guy's Hospital), Deborah Stocken(Cancer Research UK Clinical Trials Unit), Nick Dand(King's College London), Katherine Payne(University of Manchester), Katarzyna Grys(King's College London), Chrysanthi Ainali(King's College London), Nick J. Reynolds(Newcastle upon Tyne Hospitals NHS Foundation Trust), Paola Di Meglio(King's College London), Frank O. Nestlé(Guy's and St Thomas' NHS Foundation Trust), Jake Saklatvala(King's College London), Richard Emsley(University of Manchester), Emanuele de Rinaldis(Target (United States)), Anna Chapman(Queen Elizabeth Hospital), C.E.M. Griffiths(King's College London), Isabella Tosi(King's College London), Hemawtee Sreeneebus(King's College London), Catherine Smith(City College of San Francisco), Shane Solanky(King's College London), Hira Bahadur Ale(King's College London), Michael R. Barnes(Munich Cluster for Systems Neurology), Andrea Evans(Children's Hospital of Eastern Ontario), Richard B. Warren(Manchester Academic Health Science Centre), Zeynep Catak(King's College London)
Nature Communications
December 16, 2021
Cited by 1


Related Papers